Report of the Third Meeting of the WHO Onchocerciasis Technical Advisory Subgroup, Geneva, Switzerland, 26-28 February 2019.
| Format: | eBook |
|---|---|
| Language: | English |
| Published: |
Geneva :
World Health Organization,
2020.
|
| Edition: | 1st ed. |
| Subjects: | |
| Online Access: | Click to View |
Table of Contents:
- Intro
- Recommendations
- 1. Exclusion mapping (i.e. identification of unmapped areas where the environment is unfavourable for the presence of black flies) is important and should be undertaken before proceeding to stage 1 mapping.
- 1. Introduction
- 2. Opening session
- 2.1 Summary of the second meeting
- 2.2 Review of serological tests
- 3. Country presentations
- 3.1 Mali: nearing stop MDA
- 3.2 United Republic of Tanzania: nearing stop MDA
- 3.3 Togo: nearing stop MDA
- 3.4 Malawi: elimination mapping and nearing stop MDA studies
- 3.5 Nigeria: mapping plus a question of thresholds
- 3.6 Ghana: mapping
- 3.7 Kenya: mapping
- 3.8 Ethiopia: a question of thresholds
- 3.9 Burundi: mapping
- 4. Comparison of ELISA platforms and RDT
- 4.1 ELISA verification phase and QA for serological tests
- 4.2 ELISA standardization
- 4.3 Efforts to improve RDT: using DBS with RDT
- 4.4 Efforts to improve RDT: dual antigen onchocerciasis test strip
- 4.5 Dual antigen test strip: additional data
- 4.6 Summary of RDT versus ELISA comparison
- 4.7 Diagnostics summary
- 4.8 Discussion on ELISA and RDT
- 4.9 Recommendations on ELISA and RDT
- 5. Onchocerciasis elimination mapping
- 5.1 Identification of first-line villages
- 5.2 Sampling methods for stage 1 mapping
- 5.3 Lessons from the field on stage 1 mapping
- 5.4 Sampling methods for stage 2 mapping
- 5.5 Experience with stage 2 mapping
- 5.6 Additional lessons from pilot surveys of stage 1 and 2 mapping
- 5.7 Onchocerciasis mapping in areas co-endemic for LF
- 5.8 Recommendations on onchocerciasis elimination mapping
- 1. Exclusion mapping (or identification of unmapped areas where the environmental is unfavourable for the presence of black flies) is important and should be undertaken before proceeding to stage 1 mapping.
- 6. Maximizing the available diagnostic tools.
- 7. Updates
- 7.1 Stop MDA threshold
- 7.2 New diagnostics
- 7.3 Milestones for elimination: developing the road map to 2030
- 7.4 Pre-stop MDA assessments.


